|
FDA Announcement - Small Molecule Nitrosamines in Infusion Bags
|
|
14
|
2439
|
February 26, 2026
|
|
EMA proposes GMP update to EudraLex to address nitrosamine impurities
|
|
14
|
895
|
February 20, 2026
|
|
Construction of a modified Arrhenius equation for predicting drug nitrosation in solid dosage form -Pub
|
|
2
|
701
|
October 30, 2025
|
|
Modeling the Impact of Excipients Selection on Nitrosamine Formation towards Risk Mitigation
|
|
18
|
5131
|
September 20, 2025
|
|
Background on Purging Factor Calculation for your Risk Assessment
|
|
7
|
1457
|
August 13, 2025
|
|
Nitrosamine Risk Mitigation Calculator (by DFE Pharma)
|
|
1
|
1195
|
August 11, 2025
|
|
Analysis of N-Nitrosodimethylamine (NDMA) in Pharmaceutical Products in the Presence of High Concentration N,N-dimethylformamide (DMF) -Pub
|
|
0
|
678
|
August 8, 2025
|
|
Synthesis of Nitroso Derivatives of Dihydropyridine Calcium Channel Blockers
|
|
5
|
602
|
July 31, 2025
|
|
Addendum to ICH M7 on Risk Assessment and Control of N-Nitrosamine Impurities
|
|
8
|
2226
|
July 3, 2025
|
|
📖 Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines-Pub
|
|
2
|
943
|
May 27, 2025
|
|
What if the answer you’re looking for is already here, with someone in this community?
|
|
7
|
1258
|
May 27, 2025
|
|
FDA Generic Drugs Forum - Bioequivalence Approaches
|
|
2
|
1018
|
April 22, 2025
|
|
Nitrosamines: Mass Spectrometry-Based Analytical Procedures Criterias
|
|
6
|
4011
|
April 22, 2025
|